PD-L1 Glycosylation and Its Impact on Binding to Clinical Antibodies.

PD-L1 Glycosylation and Its Impact on Binding to Clinical Antibodies.
复制标题

DOI:
10.1021/acs.jproteome.0c00521
复制
发表时间:
2021-01-01
影响因子:
4.4
通讯作者:
Goldman R
Goldman R
中科院分区:
生物学2区
文献类型:
--
作者:
Benicky J;Sanda M;Brnakova Kennedy Z;Grant OC;Woods RJ;Zwart A;Goldman R

文献摘要

参考文献

被引文献

相似文献

Immune checkpoint inhibitors, including PD-L1/PD-1, are key regulators of immune response and promising targets in cancer immunotherapy. N-glycosylation of PD-L1 affects its interaction with PD-1 but little is known about the distribution of glycoforms at its four NXS/T sequons. We optimized LC-MS/MS methods using collision energy modulation for the site-specific resolution of specific glycan motifs. We demonstrate that PD-L1 on the surface of breast cancer cells carries mostly complex glycans with high proportion of polyLacNAc structures at the N219 sequon. Contrary to the full-length protein, the secreted form of PD-L1 expressed in breast MDA-MB-231 or HEK293 cells demonstrated minimum N219 occupancy and low contribution of the polyLacNAc structures. Molecular modeling of PD-L1/PD-1 interaction with N-glycans suggests that glycans at the N219 site of PD-L1 and N74 and N116 of PD-1 are involved in glycan-glycan interactions, but the impact of this potential interaction on the protein function remains at this point unknown. In addition, the interaction of PD-L1 with clinical antibodies is also affected by glycosylation. In conclusion, PD-L1 expressed in the MDA-MB-231 breast cancer cells carries polyLacNAc glycans mostly at the N219 sequon which displays the highest variability in occupancy and is most likely to influence the interaction with PD-1.
PD-1和PD-L1抑制剂作为癌症免疫疗法的一种形式的开发:对注册试验和未来考虑的全面综述。
DOI: 10.1186/s40425-018-0316-z
发表时间: 2018-01-23
影响因子: 10.9
作者:
Gong J;Chehrazi-Raffle A;Reddi S;Salgia R
通讯作者: Salgia R
DOI: 10.1038/nrc3239
发表时间: 2012-03-22
期刊: Nature reviews. Cancer
影响因子: --
作者:
Pardoll DM
通讯作者: Pardoll DM
DOI: 10.1093/glycob/cwv058
发表时间: 2015-12-01
期刊: GLYCOBIOLOGY
影响因子: 4.3
作者:
Hang, Ivan;Lin, Chia-wei;Aebi, Markus
通讯作者: Aebi, Markus
DOI: 10.1016/j.ccell.2019.06.008
发表时间: 2019-08-12
期刊: CANCER CELL
影响因子: 50.3
作者:
Lee, Heng-Huan;Wang, Ying-Nai;Hung, Mien-Chie
通讯作者: Hung, Mien-Chie
T细胞免疫调节中的新兴共同信号网络。
DOI: 10.4110/in.2013.13.5.184
发表时间: 2013-10
期刊: Immune network
影响因子: 6
作者:
Jung K;Choi I
通讯作者: Choi I